Genix Pharmaceuticals Corp. (GENX.V)
0.02
0.00 (0.00%)
CAD |
TSXV |
Aug 28, 16:00
Genix Pharmaceuticals Net Income (Quarterly) : -0.0784M for April 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -0.0784M |
| January 31, 2026 | -0.0516M |
| October 31, 2025 | -0.0923M |
| July 31, 2025 | -0.0835M |
| April 30, 2025 | -0.052M |
| January 31, 2025 | -0.1073M |
| October 31, 2024 | 0.154M |
| July 31, 2024 | -0.0822M |
| April 30, 2024 | -0.0859M |
| January 31, 2024 | -0.0591M |
| October 31, 2023 | -3.770M |
| July 31, 2023 | -0.1641M |
| April 30, 2023 | -0.234M |
| January 31, 2023 | -0.227M |
| October 31, 2022 | -0.2556M |
| July 31, 2022 | -0.2524M |
| April 30, 2022 | -0.2275M |
| January 31, 2022 | -0.3385M |
| October 31, 2021 | -0.3686M |
| July 31, 2021 | -0.4885M |
| April 30, 2021 | -0.4023M |
| January 31, 2021 | -0.3932M |
| October 31, 2020 | -0.5631M |
| July 31, 2020 | -0.0713M |
| April 30, 2020 | -0.0466M |
| Date | Value |
|---|---|
| January 31, 2020 | -0.0378M |
| October 31, 2019 | -0.0267M |
| July 31, 2019 | -0.0388M |
| April 30, 2019 | -0.1014M |
| January 31, 2019 | -0.0378M |
| October 31, 2018 | 0.0093M |
| July 31, 2018 | 0.0643M |
| April 30, 2018 | -0.0423M |
| January 31, 2018 | -0.0207M |
| October 31, 2017 | 0.0537M |
| July 31, 2017 | -0.0477M |
| April 30, 2017 | -0.0384M |
| January 31, 2017 | -0.027M |
| October 31, 2016 | 0.0082M |
| July 31, 2016 | -0.0333M |
| April 30, 2016 | -0.0837M |
| January 31, 2016 | -0.0202M |
| October 31, 2015 | -0.1194M |
| July 31, 2015 | -0.1946M |
| April 30, 2015 | -0.1461M |
| January 31, 2015 | -0.0859M |
| October 31, 2014 | -0.0476M |
| July 31, 2014 | -0.1113M |
| April 30, 2014 | 0.1775M |
| January 31, 2014 | 0.013M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Vitality Products, Inc. | -0.0468M |
| LSL Pharma Group, Inc. | -2.242M |
| Leef Brands, Inc. | -1.848M |
| NeutriSci International, Inc. | -- |
| Jamieson Wellness, Inc. | 18.61M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.0784M |
| EPS Diluted (Quarterly) | -0.0013 |
| Enterprise Value | 1.983M |
| Earnings Yield | -25.00% |
| Normalized Earnings Yield | -25.00 |